Cite
Corrigendum to 'Bridged bicyclic vasopressin receptor antagonists with V2-selective or dual V1a/V2 activity'
MLA
William J. Hoekstra, et al. “Corrigendum to ‘Bridged Bicyclic Vasopressin Receptor Antagonists with V2-Selective or Dual V1a/V2 Activity.’” Bioorganic & Medicinal Chemistry Letters, vol. 14, June 2004, p. 3363. EBSCOhost, https://doi.org/10.1016/j.bmcl.2004.04.002.
APA
William J. Hoekstra, Patricia Andrade-Gordon, Alexey B. Dyatkin, Joseph W. Gunnet, William Hageman, Keith T. Demarest, Lawrence de Garavilla, Dennis J. Hlasta, Richard Look, & Bruce E. Maryanoff. (2004). Corrigendum to “Bridged bicyclic vasopressin receptor antagonists with V2-selective or dual V1a/V2 activity.” Bioorganic & Medicinal Chemistry Letters, 14, 3363. https://doi.org/10.1016/j.bmcl.2004.04.002
Chicago
William J. Hoekstra, Patricia Andrade-Gordon, Alexey B. Dyatkin, Joseph W. Gunnet, William Hageman, Keith T. Demarest, Lawrence de Garavilla, Dennis J. Hlasta, Richard Look, and Bruce E. Maryanoff. 2004. “Corrigendum to ‘Bridged Bicyclic Vasopressin Receptor Antagonists with V2-Selective or Dual V1a/V2 Activity.’” Bioorganic & Medicinal Chemistry Letters 14 (June): 3363. doi:10.1016/j.bmcl.2004.04.002.